AJR Custom publishing of AJR articles and ARRS Cat. Course
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alexander, M. C.
Right arrow Articles by Biesemier, K. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alexander, M. C.
Right arrow Articles by Biesemier, K. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Hotlight (NEW!)
Right arrow
What's Hotlight?
DOI:10.2214/AJR.04.0582
AJR 2006; 187:29-37
© American Roentgen Ray Society


Original Research

Association of Stellate Mammographic Pattern with Survival in Small Invasive Breast Tumors

M. Camille Alexander1, Bonnie C. Yankaskas2 and Karl W. Biesemier3

1 Department of Breast Imaging, CentraHealth/Virginia Baptist Hospital, 1330 Oak Ln., Suite 202, Lynchburg, VA 24503.
2 Department of Radiology, CB 7515, Chapel Hill, NC 27599-7515.
3 Pathology Consultants of Central Virginia, Lynchburg, VA 24501.

OBJECTIVE. We tested whether the stellate mammographic pattern of presentation of small breast tumors is a better indicator of survival than other patterns.

MATERIALS AND METHODS. Patients with primary invasive breast cancer diagnosed in 1993-1997 were grouped according to the size of the lesion: 0.1-0.9 cm and 1.0-1.4 cm. Each tumor was placed in one of five mammographic prognostic categories: stellate without calcifications; circular without calcifications; and calcifications with or without tumor mass in a casting, crushed-stone, or other (powdery, punctuate, or round) pattern. To assess reproducibility, a second radiologist gave an independent interpretation in the first 109 cases. Descriptive data were stratified by tumor size, and tests of association were done with an extension of Fisher's exact test. Odds ratios and confidence intervals were computed. Weighted log-rank test and Kaplan-Meier survival curves were used to compare breast cancer survival in the stellate group compared with the other groups.

RESULTS. Two hundred one consecutive patients with a median follow-up period of 7.4 years were identified. There were nine breast cancer deaths. The stellate morphologic pattern was most common (91 [45.3%] of 201 cases), yet there was only one breast cancer death in this group (survival rate, 98.9%; 95% confidence interval [CI], 96.7-100%). In the group of stellate lesions smaller than 1.0 cm, 67.6% (25/37) of the tumors were well-differentiated without lymph node metastasis (30 [96.8%] of 31 cases), and there were no deaths. In the group of stellate lesions measuring 1.0-1.4 cm, 66.7% (36/54) of the tumors were well-differentiated with a 19.6% risk of lymph node metastasis, one death, and a survival rate of 98.1% (52/53; 95% CI, 94.4-100%). Circular tumors accounted for 29.9% (60/201) of tumors and 55.6% (5/9) of breast cancer deaths. Casting and crushed-stone microcalcifications were associated with 33.3% (3/9) of disease-specific deaths. A weighted kappa value of 0.89 (CI, 0.83-0.94) indicated very high agreement of pattern assignment.

CONCLUSION. Stellate tumors had a significantly better survival prognosis than tumors with other patterns even though there were no differences in treatment. By recognizing these small malignant lesions, trained radiologists may be able to identify tumors that pose negligible risk of breast cancer death.

Keywords: breast cancer • mammography • prognosis • stellate


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Roentgenol.Home page
A. A. Luck, A. J. Evans, J. J. James, E. A. Rakha, E. C. Paish, A. R. Green, and I. O. Ellis
Breast Carcinoma with Basal Phenotype: Mammographic Findings
Am. J. Roentgenol., August 1, 2008; 191(2): 346 - 351.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
Y. Wang, D. M. Ikeda, B. Narasimhan, T. A. Longacre, R. J. Bleicher, S. Pal, R. J. Jackman, and S. S. Jeffrey
Estrogen Receptor-Negative Invasive Breast Cancer: Imaging Features of Tumors with and without Human Epidermal Growth Factor Receptor Type 2 Overexpression
Radiology, February 1, 2008; 246(2): 367 - 375.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
C. J. D'Orsi and F. M. Hall
BI-RADS Lexicon Reemphasized
Am. J. Roentgenol., November 1, 2006; 187(5): W557 - W557.
[Full Text] [PDF]


Home page
Am. J. Roentgenol.Home page
M. C. Alexander and B. C. Yankaskas
Reply
Am. J. Roentgenol., November 1, 2006; 187(5): W559 - W559.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Roentgen Ray Society.